- UniDoc (CSE:UDOC) announced the successful acquisition of the AGNES Connect software from AMD Telemedicine, a move aimed at accelerating the expansion and enhancement of UniDoc’s NEIL Connect software platform
- The acquisition includes several assets such as the name “AMD Telemedicine,” related goodwill, the AGNES Connect software, and associated intellectual property, customer subscriptions, and accounts
- AGNES Connect is a secure, encrypted, cloud-based clinical examination platform recognized for its robust telemedicine capabilities
- UniDoc Health Corp. (CSE:UDOC) opened trading at $0.34
UniDoc (CSE:UDOC) announced the successful acquisition of the AGNES Connect software from AMD Telemedicine, a move aimed at accelerating the expansion and enhancement of UniDoc’s NEIL Connect software platform. The acquisition, finalized on March 18th, 2025, includes several assets such as the name “AMD Telemedicine,” related goodwill, the AGNES Connect software, and associated intellectual property, customer subscriptions, and accounts.
“The AGNES Connect software forms the foundation of UniDoc’s NEIL Connect software platform, and I am excited to complete this acquisition and bring the ownership and future development of this software in house,” UniDoc’s CEO, Antonio Baldassarre said in a media release. “Additionally, AGNES Connect has been in commercial operation for several years and has established a national and international customer network. We look forward to supporting current subscribers and to build upon this existing customer base. For UniDoc, AGNES Connect represents an additional opportunity to generate sustainable revenue for the company.”
Highlights of the acquisition include:
- Accelerated expansion: The acquisition will accelerate the expansion and enhancement of UniDoc’s NEIL Connect software platform.
- Customer access: UniDoc gains immediate access to existing AGNES Connect customers and plans to continue supporting and expanding this client base.
- Enhanced telehealth offering: The acquisition strengthens UniDoc’s integrated AI-driven telehealth offering with secure data-sharing and EMR integration capabilities.
AGNES Connect is a secure, encrypted, cloud-based clinical examination platform recognized for its robust telemedicine capabilities. The software enables healthcare providers to capture and securely exchange medical data, documents, and images in real-time alongside high-quality video conferencing. AGNES Connect seamlessly integrates into healthcare facilities’ electronic health record (EHR) systems, simplifying clinical workflows and documentation.
Upon closing the acquisition, UniDoc intends to continue supporting and expanding the existing AGNES Connect customer base, delivering improved software updates and enhanced customer service. The NEIL Connect platform, currently integrated with partners Carefluence and DocBox software, leverages advanced artificial intelligence (AI) to facilitate more accurate intake/triage (MediOrbis) and more efficient patient monitoring (DocBox), further supporting UniDoc’s mission to bridge gaps in healthcare accessibility and quality.
Under the terms of the agreement, UniDoc paid AMD US$175,000 in cash plus a revenue share. This strategic acquisition is expected to enhance UniDoc’s capabilities and expand its market presence by leveraging the established customer network of AGNES Connect.
Vancouver-based UniDoc Health is developing an e-health solution for the delivery of telehealth.
UniDoc Health Corp. (CSE:UDOC) opened trading at $0.34 per share.
Join the discussion: Find out what everybody’s saying about this health care stock on the UniDoc Health Corp. Bullboard investor discussion forum, and check out the rest of Stockhouse’s stock forums and message boards. The material provided in this article is for information only and should not be treated
as investment advice. For full disclaimer information, please click here.
(Top image: UniDoc Health Corp.)